Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Cowen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Physical Chemistry Chemical Physics : PCCP|September 4, 2009
DRIFTS studies on the photodegradation of tannic acid as a model for HULIS in atmospheric aerosolsScott Cowen, Hind A Al-Abadleh
Environmental Science & Technology|April 16, 2008
Adsorption thermodynamics of p-arsanilic acid on iron (oxyhydr)oxides: in-situ ATR-FTIR studiesSarah Depalma, Scott Cowen, Tuan Hoang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 10, 2008
A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behaviorRobyn Mary Brown, Jennifer Lynn Short, Michael Scott Cowen, et al.
Drug Discovery Today|May 16, 2016
An improved model for fragment-based lead generation at AstraZenecaNathan Fuller, Loredana Spadola, Scott Cowen, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinasesJeffrey W Johannes, Claudio Chuaqui, Scott Cowen, et al.
Structure (London, England : 1993)|July 26, 2011
Structural basis of substrate methylation and inhibition of SMYD2Andrew D Ferguson, Nicholas A Larsen, Tina Howard, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinasesTao Wang, Michael A Block, Scott Cowen, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activityPaul D Lyne, Brian Aquila, Donald J Cook, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Physical Chemistry Chemical Physics : PCCP|September 4, 2009
DRIFTS studies on the photodegradation of tannic acid as a model for HULIS in atmospheric aerosolsScott Cowen, Hind A Al-Abadleh
Environmental Science & Technology|April 16, 2008
Adsorption thermodynamics of p-arsanilic acid on iron (oxyhydr)oxides: in-situ ATR-FTIR studiesSarah Depalma, Scott Cowen, Tuan Hoang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 10, 2008
A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behaviorRobyn Mary Brown, Jennifer Lynn Short, Michael Scott Cowen, et al.
Drug Discovery Today|May 16, 2016
An improved model for fragment-based lead generation at AstraZenecaNathan Fuller, Loredana Spadola, Scott Cowen, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinasesJeffrey W Johannes, Claudio Chuaqui, Scott Cowen, et al.
Structure (London, England : 1993)|July 26, 2011
Structural basis of substrate methylation and inhibition of SMYD2Andrew D Ferguson, Nicholas A Larsen, Tina Howard, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinasesTao Wang, Michael A Block, Scott Cowen, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activityPaul D Lyne, Brian Aquila, Donald J Cook, et al.
Pageof 1